Economic value of improved accuracy for self-monitoring of blood glucose devices for type 1 and type 2 diabetes in England

Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force

Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A. H., Mauskopf, J., & Loder, E. (2013) · Value in Health · doi:10.1016/j.jval.2013.02.002 · Cited by 1,998 · see citing works

Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus

Selvin, E., Marinopoulos, S., Berkenblit, G., Rami, T., Brancati, F. L., Powe, N. R., & Golden, S. H. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-6-200409210-00007 · Cited by 1,657 · see citing works

Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies

Weinstein, M. C., O'Brien, B., Hornberger, J., Jackson, J., Johannesson, M., McCabe, C., & Luce, B. R. (2003) · Value in Health · doi:10.1046/j.1524-4733.2003.00234.x · Cited by 1,172 · see citing works

The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)

STEVENS, R. J., KOTHARI, V., ADLER, A. I., & STRATTON, I. M. (2001) · Clinical Science · doi:10.1042/cs20000335 · Cited by 1,084 · see citing works

Handling Uncertainty in Cost-Effectiveness Models

Briggs, A. H. (2000) · PharmacoEconomics · doi:10.2165/00019053-200017050-00006 · Cited by 806 · see citing works

Frequency of Severe Hypoglycemia Requiring Emergency Treatment in Type 1 and Type 2 Diabetes

Leese, G. P., Wang, J., Broomhall, J., Kelly, P., Marsden, A., Morrison, W., Frier, B. M., Morris, A. D., & For the DARTS/MEMO Collaboration (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1176 · Cited by 559 · see citing works

Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants

Miller, K. M., Beck, R. W., Bergenstal, R. M., Goland, R. S., Haller, M. J., McGill, J. B., Rodriguez, H., Simmons, J. H., Hirsch, I. B., & for the T1D Exchange Clinic Network (2013) · Diabetes Care · doi:10.2337/dc12-1770 · Cited by 505 · see citing works

UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82

Hayes, A. J., Leal, J., Gray, A. M., Holman, R. R., & Clarke, P. M. (2013) · Diabetologia · doi:10.1007/s00125-013-2940-y · Cited by 495 · see citing works

The Absence of a Glycemic Threshold for the Development of Long-Term Complications: The Perspective of the Diabetes Control and Complications Trial

Diabetes Control and Complications Trial (DCCT) Research Group (1996) · Diabetes · doi:10.2337/diab.45.10.1289 · Cited by 452 · see citing works

Model of Complications of NIDDM: II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia

Eastman, R. C., Javitt, J. C., Herman, W. H., Dasbach, E. J., Copley‐Merriman, C., Maier, W. C., Dong, F., Manninen, D. L., Zbrozek, A. S., Kotsanos, J. G., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.5.735 · Cited by 333 · see citing works

Model of Complications of NIDDM: I. Model construction and assumptions

Eastman, R. C., Javitt, J. C., Herman, W. H., Dasbach, E. J., Zbrozek, A. S., Dong, F., Manninen, D. L., GARFIELD, S. A., Copley‐Merriman, C., Maier, W. C., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.5.725 · Cited by 259 · see citing works

Cardiovascular Disease, Mortality, and Retinal Microvascular Characteristics in Type 1 Diabetes

Klein, R., Klein, R., McBride, P. E., Cruickshanks, K. J., Palta, M., Knudtson, M. D., Moss, S. E., & Reinke, J. O. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.17.1917 · Cited by 234 · see citing works

Associations of Mortality and Diabetes Complications in Patients With Type 1 and Type 2 Diabetes

Cusick, M., Meleth, A. D., Agrón, E., Fisher, M. R., Reed, G. F., Knatterud, G. L., Barton, F. B., Davis, M. D., Ferris, F. L., & Chew, E. Y. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.617 · Cited by 196 · see citing works

The impact of diabetes‐related complications on healthcare costs: new results from the UKPDS (UKPDS 84)

Alva, M. L., Gray, A. M., Mihaylova, B., Leal, J., & Holman, R. R. (2014) · Diabetic Medicine · doi:10.1111/dme.12647 · Cited by 191 · see citing works

Potential Short-Term Economic Benefits of Improved Glycemic Control

Menzin, J., Langley-Hawthorne, C., Friedman, M., Boulanger, L., & Cavanaugh, R. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.51 · Cited by 176 · see citing works

Modelling Methods for Pharmacoeconomics and Health Technology Assessment: An Overview and Guide

Stahl, J. E. (2008) · PharmacoEconomics · doi:10.2165/00019053-200826020-00004 · Cited by 171 · see citing works

Relationship Between Glycemic Control and Diabetes-Related Hospital Costs in Patients with Type 1 or Type 2 Diabetes Mellitus

Menzin, J., Korn, J. R., Cohen, J., Lobo, F., Zhang, B., Friedman, M., & Newmann, P. (2010) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2010.16.4.264 · Cited by 165 · see citing works

Costs of managing severe hypoglycaemia in three European countries

Hammer, M., Lammert, M., Mejías, S. M., Kern, W., & Frier, B. M. (2009) · Journal of Medical Economics · doi:10.3111/13696990903336597 · Cited by 151 · see citing works

Estimating the impact of better management of glycaemic control in adults with Type 1 and Type 2 diabetes on the number of clinical complications and the associated financial benefit

Baxter, M., Hudson, R., Mahon, J., Bartlett, C., Samyshkin, Y., Alexiou, D., & Hex, N. (2016) · Diabetic Medicine · doi:10.1111/dme.13062 · Cited by 126 · see citing works

The Cost-Effectiveness of Continuous Glucose Monitoring in Type 1 Diabetes

Huang, E. S., O’Grady, M. J., Basu, A., Winn, A. N., John, P. M., Lee, J. M., Meltzer, D. O., Kollman, C., Laffel, L. M., Tamborlane, W. V., et al. (2010) · Diabetes Care · doi:10.2337/dc09-2042 · Cited by 117 · see citing works

Impact of Blood Glucose Self-Monitoring Errors on Glucose Variability, Risk for Hypoglycemia, and Average Glucose Control in Type 1 Diabetes: An <i>In Silico</i> Study

Breton, M. D., & Kovatchev, B. P. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400309 · Cited by 103 · see citing works

Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes

McQueen, R. B., Ellis, S. L., Campbell, J. D., Nair, K. V., & Sullivan, P. W. (2011) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-9-13 · Cited by 75 · see citing works

Development and Application of a Model to Estimate the Impact of Type 1 Diabetes on Health-Related Quality of Life

Wu, S., Sainfort, F., Tomar, R. H., Tollios, J. L., Fryback, D. G., Klein, R., & Klein, B. E. K. (1998) · Diabetes Care · doi:10.2337/diacare.21.5.725 · Cited by 62 · see citing works

Modelling Cost Effectiveness of Insulin Glargine for the Treatment of Type 1 and 2 Diabetes in Canada

Grima, D. T., Thompson, M. F., & Sauriol, L. (2007) · PharmacoEconomics · doi:10.2165/00019053-200725030-00007 · Cited by 49 · see citing works

Assessing the cost‐effectiveness of Type 1 diabetes interventions: the Sheffield Type 1 Diabetes Policy Model

Thokala, P., Kruger, J., Brennan, A., Basarir, H., Duenas, A., Pandor, A., Gillett, M., Elliott, J., & Heller, S. R. (2013) · Diabetic Medicine · doi:10.1111/dme.12371 · Cited by 39 · see citing works

Accuracy of Blood Glucose Meters for Self-Monitoring Affects Glucose Control and Hypoglycemia Rate in Children and Adolescents with Type 1 Diabetes

Boettcher, C., Dost, A., Wudy, S. A., Flechtner-Mors, M., Borkenstein, M., Schiel, R., Weitzel, D., Bechtold-Dalla Pozza, S., Wolf, J., Holl, R. W., et al. (2015) · Diabetes Technology &amp; Therapeutics · doi:10.1089/dia.2014.0262 · Cited by 35 · see citing works

Association between glycemic control and short-term healthcare costs among commercially insured diabetes patients in the United States

Aagren, M., & Luo, W. F. (2011) · Journal of Medical Economics · doi:10.3111/13696998.2010.548432 · Cited by 33 · see citing works

Economic and Clinical Aspects of Diabetes Regarding Self-Monitoring of Blood Glucose

Schnell, O., Hummel, M., & Weber, C. (2008) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0017 · Cited by 20 · see citing works

Association Between Glycated Hemoglobin and Health Utility for Type 1 Diabetes

McQueen, R. B., Ellis, S. L., Maahs, D. M., Anderson, H. D., Nair, K. V., Libby, A. M., & Campbell, J. D. (2014) · Patient · doi:10.1007/s40271-014-0045-4 · Cited by 17 · see citing works

Economic value of improved accuracy for self-monitoring of blood glucose devices for type 1 diabetes in Canada

McQueen, R. B., Breton, M. D., Ott, M., Koa, H., Beamer, B., & Campbell, J. D. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815599551 · Cited by 17 · see citing works

Higher Accuracy of Self-Monitoring of Blood Glucose in Insulin-Treated Patients in Germany: Clinical and Economical Aspects

Schnell, O., Erbach, M., & Wintergerst, E. S. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700413 · Cited by 15 · see citing works

Determinants of neointimal proliferation and stent coverage after intracoronary therapy with drug-eluting devices in stable coronary artery disease: role of endothelial progenitor cells and interleukin-1 family cytokines.

Otto, S., Nitsche, K., Jung, C., Gassdorf, J., Janiak, F., Goebel, B., Figulla, H. R., & Poerner, T. C. (2014) · PubMed · Cited by 3 · see citing works

Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus

Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351 · see citing works

Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus

Sacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad080 · Cited by 157 · see citing works

Cost and cost-effectiveness of large-scale screening for type 1 diabetes in Colorado

McQueen, R. B., Geno Rasmussen, C., Waugh, K., Frohnert, B. I., Steck, A. K., Yu, L., Baxter, J., & Rewers, M. (2020) · Diabetes Care · doi:10.2337/dc19-2003 · Cited by 138 · see citing works

Toward a Framework for Outcome-Based Analytical Performance Specifications: A Methodology Review of Indirect Methods for Evaluating the Impact of Measurement Uncertainty on Clinical Outcomes

Smith, A. F., Shinkins, B., Hall, P. S., Hulme, C. T., & Messenger, M. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2018.300954 · Cited by 46 · see citing works

Pan-European Economic Analysis to Identify Cost Savings for the Health Care Systems as a Result of Integrating Glucose Monitoring Based Telemedical Approaches Into Diabetes Management

Fritzen, K., Basinska, K., Rubio-Almanza, M., Nicolucci, A., Kennon, B., Vergès, B. L., Zakrzewska, K. E., & Schnell, O. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819835172 · Cited by 17 · see citing works

Cost‐effectiveness of dapagliflozin as an adjunct to insulin for the treatment of type 1 diabetes mellitus in the United Kingdom

Bennett, H., Tank, A., Evans, M., Bergenheim, K., & McEwan, P. C. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13992 · Cited by 8 · see citing works

Clinical Study of a High Accuracy Green Design Blood Glucose Monitor Using an Innovative Optical Transmission Absorbance System

Moriuchi, T., Otaki, Y., Satou, H., Chai, F., Hayashida, Y., Aikawa, R., Sugiyama, T., & Sode, K. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211060865 · Cited by 3 · see citing works

Budget Impact of Improved Diabetes Management by Utilization of Glucose Meters With a Color-Range Indicator—Comparison of Five European Healthcare Systems

Fritzen, K., Basinska, K., Stautner, C., Braun, K. F., Rubio-Almanza, M., Nicolucci, A., Kennon, B., Vergès, B. L., Hosny, Y., & Schnell, O. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819864665 · Cited by 3 · see citing works

Cost–effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries

Szilberhorn, L., Zelei, T., Vellekoop, H., Huygens, S. A., Versteegh, M., Mölken, M. R., Koleva‐Kolarova, R., Tsiachristas, A., Wordsworth, S., & Nagy, B. (2023) · Personalized Medicine · doi:10.2217/pme-2023-0017 · Cited by 3 · see citing works

Looking back to look forward: can analytical performance be successfully linked to health outcomes in laboratory medicine?

Bell, K., Lord, S. J., Leeflang, M., Horvath, A. R., & Bossuyt, P. M. (2026) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2026-0643 · Cited by 1 · see citing works

Consequences of SMBG systems inaccuracy

Campos-Náñez, E., & Fortwaengler, K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816714-4.00004-1

Cost effectiveness analysis of self-monitoring of blood glucose for patients with type 2 diabetes

Mohammadi, A., Darvishi, A., Daroudi, R., Olyaeemanesh, A., Nasli‐Esfahani, E., Shafiee, G., Heshmat, R., & Takian, A. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-026-01884-w

Economic value of improved accuracy for self-monitoring of blood glucose devices for type 1 diabetes in Canada

McQueen, R. B., Breton, M. D., Ott, M., Koa, H., Beamer, B., & Campbell, J. D. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815599551 · Cited by 17 · see citing works

Economic Value Of Improved Accuracy For Self-Monitoring Of Blood Glucose Devices For Type 1 Diabetes

McQueen, R., Breton, M. D., Ott, M. A., Koa, H., Beamer, B., & Campbell, J. (2015) · Value in Health · doi:10.1016/j.jval.2015.03.025

Value of Improved Accuracy for Self-Monitoring of Blood Glucose Devices in Germany

McQueen, R., Breton, M. D., Ott, M. A., & Campbell, J. (2016) · Value in Health · doi:10.1016/j.jval.2016.09.2007

Impact of a Reduced Error Range of SMBG in Insulin-treated Patients in Germany

Schnell, O., & Erbach, M. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296813516206 · Cited by 10 · see citing works

PDB29 COST-EFFECTIVENESS ANALYSIS OF THE SELF-MONITORING OF BLOOD GLUCOSE DEVICES FOR TYPE 1 AND TYPE 2 DIABETES MELLITUS IN THE RUSSIAN FEDERATION

Yagudina, R. I., Kulikov, A. Y., Serpik, V. G., Kostina, E., & Protsenko, M. V. (2019) · Value in Health · doi:10.1016/j.jval.2019.09.911 · Cited by 1 · see citing works